Investing
Rapid Micro Biosystems reports 30% annual revenue growth
© Reuters.
LOWELL, Mass. – Rapid Micro Biosystems, Inc. (NASDAQ:RPID), a life sciences technology company, announced preliminary unaudited revenue figures indicating significant growth for both the fourth quarter and the full year of 2023. The company, which specializes in automating microbial quality control testing for healthcare product manufacturing, reported anticipated fourth-quarter revenue between $6.2M and $6.4M, marking an approximate 45% increase from the same period the previous year.
For the full year of 2023, Rapid Micro Biosystems expects total revenue to be in the range of $22.4M to $22.6M, representing over 30% growth compared to the prior year. The company attributes this performance to the placement of 16 new Growth Direct systems and the completion of 18 new customer system validations within the year.
As of December 31, 2023, the company finished with approximately $95M in cash and investments. This financial position is expected to provide the company with a cash runway extending at least into the second half of 2026.
Rapid Micro Biosystems also highlighted that its Growth Direct platform has been chosen by Samsung (KS:) Biologics for automating microbiology quality control testing. Moreover, the company’s systems are now placed with all commercially approved CAR-T therapy manufacturers, marking a notable achievement in its sector.
In terms of upcoming events, the company is scheduled to present at the 42nd annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2024. The presentation will be webcast live and made available for replay on the company’s investor relations website.
The preliminary financial results are subject to adjustment as the company completes its year-end financial close processes. Rapid Micro Biosystems plans to announce complete financial results for the fourth quarter and full year 2023 in March, along with hosting a webcast to discuss these results and the company’s outlook for 2024.
This report is based on a press release statement from Rapid Micro Biosystems, Inc.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Read the full article here
VP Exec’s Top Tips for Negotiating and Relationship-Building
Why the Smallest Details Mean the Most in Marketing
Hurricane Helene Hits Spruce Pine Mine, Quartz Used for Tech
How Sustainable Business Practices Can Drive Global Success
Britain’s FTSE 100 rises as oil price jump boosts energy shares By Reuters
3 Steps You Can’t Miss When Growing Your Business
How I Transformed My Business by Letting Go of Low-Value Tasks
Here’s the Typical American’s Income at Every Age. How Do You Compare?
Germany stocks lower at close of trade; DAX down 0.65% By Investing.com
How Your Body Language Can Help Win a Disagreement
Debt ceiling debate and its effect on the U.S. dollar
Debt ceiling default: Still no deal between parties
Stovall: If the U.S. defaults on its debt, all S&P 500 sectors will likely fall
What China's weaker-than-expected economy could mean for U.S. markets
A ‘Big Short’ investor sees financial disaster brewing in housing markets — again
-
Side Hustles7 days ago3 Steps You Can’t Miss When Growing Your Business
-
Investing7 days agoHow I Transformed My Business by Letting Go of Low-Value Tasks
-
Make Money7 days agoHere’s the Typical American’s Income at Every Age. How Do You Compare?
-
Investing7 days agoGermany stocks lower at close of trade; DAX down 0.65% By Investing.com
-
Side Hustles5 days agoHow Your Body Language Can Help Win a Disagreement
-
Side Hustles6 days agoHow to Develop Empowered Leaders Within Your Own Team
-
Side Hustles4 days agoHow to Be Unapologetically You and Why It Matters
-
Passive Income5 days agoAre You Running Your Business, or Is Your Business Running You?